Howard Wang, MD
-
Specialty: Pediatric Plastic Surgery
View Expertise -
Primary Location: 29099 Health Campus Dr (18 mi.)
Other Locations - Languages Spoken: English
Office Locations
University Hospitals (18 mi.)
29099 Health Campus Dr
Bldg 3 Ste 340
Westlake, OH 44145
440-446-8600
UH Rainbow Babies & Children's Hospital (0 mi.)
11100 Euclid Ave
Ste 170
Cleveland, OH 44106
216-844-7770
UH Minoff Health Center (7 mi.)
3909 Orange Pl
Ste 4300
Beachwood, OH 44122
440-446-8600
UH Westlake Health Center (15 mi.)
960 Clague Rd
Ste 1600
Westlake, OH 44145
440-250-2800
UH RBC Perrico Health Center (15 mi.)
4176 State Route 306
Ste 300
Willoughby, OH 44094
216-844-2273
Biography: Howard Wang, MD
Expertise
Titles
- Division Chief, Plastic Surgery, UH Rainbow Babies and Children's Hospital
Education
Fellowship | Cranio-Maxillofacial Surgery/Pediatric Plastic Surgery
Cranio-Maxillofacial Surgery/Pediatric Plastic Surgery - SEATTLE CHILDREN's HOSPITAL (2020 - 2021)
Residency | Plastic Surgery
Plastic Surgery - Johns Hopkins Hospital (2013 - 2020)
Medical Education
University Of Maryland School Of Medicine (2013)
Undergraduate
Washington University In St Louis (2008)
About
Howard Wang, MD is a pediatric plastic and craniofacial surgeon at University Hospitals Rainbow Babies & Children’s Hospital and assistant professor of plastic surgery at Case Western Reserve University School of Medicine. Dr. Wang sees patients at UH Rainbow Babies & Children Hospital, UH Minoff Health Center at Chagrin Highlands, and UH St. John Medical Center.
Dr. Wang earned his undergraduate degree from Washington University in St. Louis and attended University of Maryland School of Medicine. During medical school, he was inducted into Alpha Omega Alpha Honor Society and was one of the few medical students nationwide to be selected into the Medical Research Scholars Program at the National Institutes of Health, where he conducted translational research on the bone biology of McCune Albright syndrome/Fibrous Dysplasia. Subsequently, he completed his plastic and reconstructive surgery training at the Johns Hopkins and University of Maryland combined residency program in Baltimore. He then pursued fellowship training in craniofacial surgery at one of the premier craniofacial centers in the country at the University of Washington and Seattle Children’s hospital prior to joining the team at UH Rainbow.
Dr. Wang’s clinical practice focuses on pediatric and adult craniomaxillofacial surgery, including management of cleft lip/palate, craniosynostosis, craniofacial microsomia, facial paralysis, dentofacial discrepancies (jaw surgery), vascular anomalies, ear reconstruction and reconstruction after facial trauma.
Dr. Wang’s current research areas include clinical outcomes of craniofacial surgery, neurodevelopmental outcomes of craniosynostosis, and translational research in bone biology and bone healing. He has published over 40 peer-reviewed articles and book chapters and presented at various regional and national meetings.
Here in Cleveland, Dr. Wang enjoys exploring the beautiful park system and numerous artistic and historical institutions with his wife and daughter. Dr. Wang feels fortunate to have the privilege to take care of children with craniofacial differences, and as a parent of a young child, he strives to provide the same quality of care to his patients and their families that he would expect for his own child.
Featured Videos
Watch to find out more about this University Hospitals provider.
Related Blog Articles
Ear Molding for Newborns Has Many Benefits
Congenital deformities of the outer ears can be easily corrected without surgery – but parents must act within a few weeks of birth.
Industry Relationships
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Howard Wang did not disclose any Outside Relationships with Industry.